SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-006659
Filing Date
2021-05-10
Accepted
2021-05-10 16:03:31
Documents
58
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q imgn-20210331x10q.htm   iXBRL 10-Q 1017837
2 EX-10.1 imgn-20210331xex10d1.htm EX-10.1 169302
3 EX-31.1 imgn-20210331xex31d1.htm EX-31.1 10918
4 EX-31.2 imgn-20210331xex31d2.htm EX-31.2 10954
5 EX-32 imgn-20210331xex32.htm EX-32 10004
  Complete submission text file 0001558370-21-006659.txt   5396402

Data Files

Seq Description Document Type Size
6 EX-101.SCH imgn-20210331.xsd EX-101.SCH 43658
7 EX-101.CAL imgn-20210331_cal.xml EX-101.CAL 35841
8 EX-101.DEF imgn-20210331_def.xml EX-101.DEF 155945
9 EX-101.LAB imgn-20210331_lab.xml EX-101.LAB 426341
10 EX-101.PRE imgn-20210331_pre.xml EX-101.PRE 296238
11 EXTRACTED XBRL INSTANCE DOCUMENT imgn-20210331x10q_htm.xml XML 874909
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-17999 | Film No.: 21907020
SIC: 2834 Pharmaceutical Preparations